Still, the magnitude of the difference, double to quadruple the weight loss percentage, is too large to dismiss as a statistical artifact
If you have type 2 diabetes, your insurance provider is more likely to cover Victoza, which contains the same active ingredient as Saxenda, liraglutide
BPC-157 has been proposed as a potential treatment of physiologically based illnesses that disproportionately affect certain patient populations, such as the COVID-19 illness, as it improves vascular integrity and immune response, reduces the pro-inflammatory profile, has an anti-inflammatory effect, and reduces the lethality of critical COVID-19 illnesses [3]
BPC 157 is a synthetic peptide, also known as a pentadecapeptide